Global Anaphylaxis Treatment Market Size Projected to Reach $8.68 Billion During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Anaphylaxis Treatment Market Expected To Expand Between 2025 And 2029?

The anaphylaxis treatment market size has shown significant expansion over recent years. It is anticipated to expand from $6.19 billion in 2024 to $6.59 billion in 2025, at a compound annual growth rate (CAGR) of 6.5%. The past growth in this market stems from factors such as the increasing occurrence of allergic reactions, a broader recognition of anaphylaxis, the greater availability of epinephrine auto-injectors, public awareness and educational initiatives, and professional training for healthcare providers.

The anaphylaxis treatment market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $8.68 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.1%. This projected growth is primarily driven by advancements in biologic therapies, personalized treatment methods, worldwide initiatives for food safety, increased patient empowerment and advocacy, and improvements in emergency medical services. Key trends expected during this period encompass innovations in auto-injectors, the use of telemedicine for managing anaphylaxis, enhancements in allergen immunotherapy, the development of biometric wearables for allergen detection, and increased collaborations in allergy research.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12105&type=smp

Which Drivers Are Supporting Growth Of The Anaphylaxis Treatment Market?

The growing occurrence of food allergies is anticipated to drive the expansion of the anaphylaxis treatment market in the future. A food allergy is defined as an immune system response to specific proteins present in food. Treatment for anaphylaxis serves to hinder the advancement of severe, potentially fatal allergic indicators impacting the skin, mucous membranes, breathing difficulties, low blood pressure, and impaired organ function. For example, data from January 2023, published by the US government agency, the Centers for Disease Control and Prevention, showed that in 2021, 31.8% of adults aged 18 and above indicated experiencing eczema, a seasonal allergy, or a food allergy. Specifically, 25.7% of adults suffered from a seasonal allergy, while 6.2% reported a food allergy, and 7.3% of people had eczema. Furthermore, an August 2024 report by the Food Standards Agency, a non-ministerial department in the UK, indicated that 296 valid case reports were submitted to the Registry from October 2021 to August 27, 2023. This figure probably represents less than 5% of all accidental reactions in the UK. Of these reports, 213 (72%) were linked to food triggers, and 208 (97.7%) involved children and young people aged 18 or under, even though only 28 clinics and 11 Accident & Emergency (A&E) departments had registered for platform access. Consequently, the increased incidence of food allergies is stimulating the expansion of the anaphylaxis treatment market.

What Are The Major Segments Identified In The Anaphylaxis Treatment Market?

The anaphylaxis treatmentmarket covered in this report is segmented –

1) By Treatment: Epinephrine; Antihistamines; Steroids; Beta-antagonists; Other Treatments

2) By Product: Tablets; Capsules; Other Products

3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

4) By Application: Food Allergy; Pollen Allergy; Dust Mites Allergy; Other Applications

Subsegments:

1) By Epinephrine: Auto-Injectors; Vials Or Syringes

2) By Antihistamines: Oral Antihistamines; Injectable Antihistamines

3) By Steroids: Oral Steroids; Injectable Steroids

4) By Beta-antagonists: Oral Beta-blockers; Injectable Beta-blockers

5) By Other Treatments: Corticosteroids; Intravenous Fluids; Other Supportive Treatments

How Are Emerging Market Trends Shaping The Anaphylaxis Treatment Industry Landscape?

Progress in product innovation is a significant trend gaining traction in the anaphylaxis treatment market. Leading companies within this market are enhancing their offerings to sustain their competitive standing. For instance, in April 2022, the Food and Drug Administration granted Fast Track designation to Aquestive Therapeutics Inc., a US-based pharmaceutical company, for AQST-109, a treatment for severe allergic reactions, including anaphylaxis. Aquestive is advancing with the clinical testing of AQST-109, which is the sole orally administered epinephrine product candidate that has shown clinical outcomes equivalent to autoinjectors (such as EpiPen and Auvi-Q) for managing allergic emergencies, including anaphylaxis.

Which Leading Companies Dominate The Anaphylaxis Treatment Market Share?

Major companies operating in the anaphylaxis treatment market include Merck & Co. Inc., Novartis International AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies, Sun Pharmaceutical Industries Ltd., Perrigo Co, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., ALK-Abelló A/S, Amphastar Pharmaceuticals Inc., Par Pharmaceutical Inc., Genentech Inc., Meridian Medical Technologies LLC, Aquestive Therapeutics Inc., Sandoz Inc., Adamis Pharmaceutical Corporation, Impax Laboratories LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report

Which Regional Markets Are Contributing Most To The Anaphylaxis Treatment Industry Expansion?

North America was the largest region in the anaphylaxis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anaphylaxis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Anaphylaxis Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12105&type=smp

Browse Through More Reports Similar to the Global Anaphylaxis Treatment Market 2025, By The Business Research Company

Phosphate Fertilizer Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/phosphate-fertilizer-global-market-report

Cumene Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cumene-global-market-report

Chemical Fertilizers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemical-fertilizers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795